Phase II study of subcutaneously administered 5‐azacytidine (NSC‐102816) in patients with metastatic malignant melanoma
Year: 1978
Type: article
Study design: Clinical Trial
Source: Medical and Pediatric Oncology
Institution: Fox Chase Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1994462732
